Given the concern about safety, a 6-week randomized trial in 55 IBD patients (of whom 38 suffered CD) comparing a low-FODMAP to a standard diet assessing safety and efficacy, showed a significant reduction in HBI and faecal calprotectin in CD patients and a slight and barely significant improvement of quality of life scores [ 88 ].
1
—
—